Episode 46: Dr. Carsten Rudolph, CEO and Managing Director at Ethris
"It's really a very important challenge we had from the very beginning, to see how to stabilize nanoparticles with the messenger RNA so they are not destroyed during nebulization." - Dr. Carsten Rudolph, CEO and Managing Director at Ethris Welcome to the latest episode of Biorasi's Few & Far Between podcast. Join host Chris O'Brien and guest, Dr. Carsten Rudolph, as they discuss the current state and bright future of nasal vaccine technology. Tune in today!
Episode 45 of the Few & Far Between: How Biotech Gets Built podcast, hosted by Chris O'Brien, titled "Episode 46: Dr. Carsten Rudolph, CEO and Managing Director at Ethris" was published on December 12, 2024 and runs 37 minutes.
December 12, 2024 ·37m · Few & Far Between: How Biotech Gets Built
Summary
"It's really a very important challenge we had from the very beginning, to see how to stabilize nanoparticles with the messenger RNA so they are not destroyed during nebulization." - Dr. Carsten Rudolph, CEO and Managing Director at Ethris Welcome to the latest episode of Biorasi's Few & Far Between podcast. Join host Chris O'Brien and guest, Dr. Carsten Rudolph, as they discuss the current state and bright future of nasal vaccine technology. Tune in today!
Episode Description
"It's really a very important challenge we had from the very beginning, to see how to stabilize nanoparticles with the messenger RNA so they are not destroyed during nebulization." - Dr. Carsten Rudolph, CEO and Managing Director at Ethris
Welcome to the latest episode of Biorasi's Few & Far Between podcast. Join host Chris O'Brien and guest, Dr. Carsten Rudolph, as they discuss the current state and bright future of nasal vaccine technology.
Tune in today!
Similar Episodes
Apr 13, 2026 ·17m
Apr 6, 2026 ·11m
Mar 30, 2026 ·17m
Mar 23, 2026
Mar 16, 2026